Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant

Journal of the American Society of Nephrology

Volumn 9, Issue 3, 1998, Pages 482-487

  Nickerson, Peter ^a,b   Jeffery, John ^a   Gough, James ^a   Mckenna, Rachel ^a   Grimm, Paue ^a   Cheang, Mary ^a   Rush, David ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Basic Medical Sciences Bldg   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A;

AGE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GRAFT SURVIVAL; HUMAN; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0031937119     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. The Canadian Multicentre Transplant Study Group: A randomized trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 309: 809-815, 1983
2. European Multicentre Trial Group: Cyclosporin in cadaveric renal transplantation: One-year follow-up of a multicentre trial. Lancet 2: 986-989, 1983
3. Tullius S, Tilney N: Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 59: 313-318, 1995
4. Paul L: Chronic renal transplant loss. Kidney Int 47: 1491-1499, 1995
5. Hunsicker L, Bennett L: Design of trials of methods to reduce late renal allograft loss: The price of success. Kidney Int 48: S120-S123, 1995
6. Kasiske B, Massy Z, Guijaro C, Ma J: Chronic renal allograft rejection and clinical trial design. Kidney Int 48: S116-S119, 1995
7. Rush D, Henry S, Jeffery J, Schroeder T, Gough J: Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 57: 208-211, 1994
8. Rush D, Jeffery J, Gough J: Sequential protocol biopsies in renal transplant patients: Clinical-pathological correlations using the Banff schema. Transplantation 59: 511-514, 1995
9. Solez K, Axelsen R, Benediktsson H, Burdick J, Cohen A, Colvin R, Croker B, Droz D: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44: 411-422, 1993
10. Flechner S, Modlin C, Serrano D, Goldfarb D, Papajcik D, Mastroianni B, Goormastic M, Novick A: Determinants of chronic renal allograft rejection in cyclosporine-treated recipients. Transplantation 62: 1235-1241, 1996
11. Almond P, Matas A, Gillingham K, Dunn D, Payne W, Gores P, Gruessner R, Najarian J: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55: 752-757, 1993
12. Isoniemi H, Nurminen M, Tikkanen M, von Willebrand E, Krogerus L, Ahonen J. Eklund B, Hockerstedt K, Salmela K, Hayry P: Risk factors predicting chronic rejection of renal allografts. Transplantation 57: 68-72, 1994
13. Paul L, Hayry P, Foegh M, Dennis M, Mihatsch M, LaRsson E, Fellstrom B: Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: Joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs. Transplant Proc 25: 2022, 1993
14. Dimény E, Wahlberg J, Larsson E, Fellstrom B: Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection? Clin Transplantation 9: 79-84, 1995
15. Yuge J, Cecka J: Sex and age effects in renal transplantation. In: Clinical Transplants, edited by Teraski P, Los Angeles, UCLA Tissue Typing Laboratory, 1991, pp 257-267
16. Isoniemi H, von Willebrand E, Krogerus L, Taskinen E, Ahonen J, Hayry P: The effect of donor age on kidney graft function and on histopathological findings. Transplant Proc 24: 328-329, 1992
17. Burke J, Pirsch J, Ramos E, Salomon D, Stablein D, Van Buren D, West J: Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med 331: 358-363, 1994
18. Tesi R, Henry M, Elkhammas E, Ferguson R: Predictors of long-term primary cadaveric renal transplant survival. Clin Transplantation 7: 345-352, 1993
19. Koyama H, Cecka J: Rejection episodes. In: Clinical Transplants, edited by Terasaki P, Cecka J, Los Angeles, UCLA Tissue Typing Laboratory, 1992, pp 391-404
20. Massy Z, Guijarro C, Wiederkehr M, Ma J, Kasiske B: Chronic renal allograft rejection: Immunologic and nonimmunologic risk factors. Kidney Int 49: 518-524, 1996
21. Basadonna G, Matas A, Gillingham K, Payne W, Dunn D, Sutherland D, Gores P, Gruessner R, Najarian J: Early versus late acute renal allograft rejection: Impact on chronic rejection. Transplantation 55: 993-995, 1993
22. Lemstrom K, Koskinen P, Hayry P: Molecular mechanisms of chronic renal allograft rejection. Kidney Int 48: S2-S10, 1995
23. Hollander A, van Saase J, Kootte A, van Dorp W, van Bockel H, Van Es L, van der Woude F: Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet 345: 610-614, 1995
24. Mihatsch M, Ryffel B, Gudat F: The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int 48: S63-S69, 1995
25. Lewis R: Long-term use of cyclosporine A does not adversely impact on clinical outcomes following renal transplantation. Kidney Int 52: S75-S78, 1995
26. Remuzzi G, Perico N: Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int 48: S70-S74, 1995
27. Isoniemi H, Krogerus L, von Willebrand E, Taskinen E, Ahonen J, Hayry P: Histopathological findings in well-functioning, long-term renal allografts. Kidney Int 41: 155-160, 1992